Skip to main content

GERON CORP

For the period ended Dec 31, 2024. Filed Feb 27, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 27, 2025

GERN$0.97-2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

CONSOLIDATED STATEMENTS OF CASH FLOWS

Year Ended December 31,
202420232022
(In thousands)
Cash flows from operating activities:
Net loss$(174,572)$(184,127)$(141,901)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization546442288
Accretion and amortization on investments, net(9,683)(11,150)(965)
Amortization of debt issuance costs/debt discount(3,108)1,0881,327
Payment on royalty agreement(2,186)
Non-cash interest expense on liabilities for sales of future royalties5,345——
Loss of extinguishment of debt1,707——
Stock-based compensation for services by non-employees135828264
Stock-based compensation for employees and directors31,18518,5268,001
Amortization of right-of-use assets675591580
Increase in allowance for doubtful accounts(251)——
Changes in assets and liabilities:
Inventory(37,971)——
Accounts receivable, net(35,695)——
Interest and other receivables(1,198)1,490(1,381)
Prepaid expenses and other assets(175)(886)(2,630)
Deposit and other assets618692(594)
Accounts payable2,435(4,029)3,503
Accrued compensation and benefits9,0492,2243,435
Accrued liabilities(4,759)7,2083,266
Operating lease liabilities(715)(640)(572)
Net cash used in operating activities(218,618)(167,743)(127,379)
Cash flows from investing activities:
Purchases of property and equipment(680)(830)(431)
Purchases of marketable securities(476,932)(475,594)(258,007)
Proceeds from maturities of marketable securities371,608296,102320,505
Net cash provided by (used in) investing activities(106,004)(180,322)62,067
Cash flows from financing activities:
Proceeds from issuances of common stock from equity plans32,68313,0722,185
Proceeds from issuance of common stock and warrants in public offering, net of paid issuance costs140,729213,33769,916
Proceeds from exercise of warrants1,394105,91215,163
Proceeds from sale of future royalties125,000——
Proceeds from debt financing, net of paid debt issuance costs and debt discounts121,12029,700—
Repayment of debt(86,554)——
Net cash provided by financing activities334,372362,02187,264
Net effect of exchange rates on cash, cash equivalents and restricted cash(12)(27)22
Net increase in cash, cash equivalents and restricted cash9,73813,92921,974
Cash, cash equivalents and restricted cash at the beginning of the period71,13857,20935,235
Cash, cash equivalents and restricted cash at the end of the period$80,876$71,138$57,209

NOTES TO FINANCIAL STATEMENTS

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.